DeepIntent

The business model centres on a specialised healthcare DSP that consolidates audience planning, media activation and outcome measurement for pharma and healthcare advertisers. DeepIntent creates value by combining identity, media and clinical or pharmacy claims data so buyers can target patient and HCP audiences and optimise campaigns towards script lift and other health outcomes, particularly across CTV and digital channels.

Revenue is primarily derived from fees associated with programmatic media bought through the platform (platform/take‑rate and, where applicable, managed‑service fees). Additional value and revenue are created through a healthcare‑specific audience marketplace where publishers and data owners list patient and HCP segments and pay transaction or activation fees, plus paid measurement and analytics capabilities that use near real‑time clinical data to measure and optimise campaigns based on prescribing outcomes. This positions the company as a vertical adtech infrastructure provider embedded in healthcare media supply chains.

DeepIntent is a United States–based healthcare advertising technology company focused on programmatic media buying for pharmaceutical and wider healthcare marketers. Its core offering is a verticalised demand‑side platform (DSP) that allows customers to plan, activate and measure omnichannel campaigns, including connected TV (CTV), display, video and audio, against patient and healthcare professional (HCP) audiences under healthcare privacy and compliance constraints.

The company generates revenue through media and platform fees on programmatic buying, transaction and data fees from a healthcare data marketplace, and paid measurement and analytics products that link ad exposure to prescription and clinical outcomes. Its customers are primarily pharmaceutical brands, biotech firms, healthcare advertisers and their media agencies and trading desks, who use the platform to target, optimise and evaluate healthcare campaigns in one environment.